About Nirrin Technologies
Nirrin Technologies is a company based in Billerica (United States) founded in 2018 by Bryan Hassell. Nirrin Technologies has raised $4.82 million across 2 funding rounds from investors including Gamma Biosciences. The company has 17 employees as of December 31, 2024. Nirrin Technologies offers products and services including Atlas. Nirrin Technologies operates in a competitive market with competitors including Unibio, Univercells Tech, Pow.Bio, Caladan Bio and BiOZEEN, among others.
- Headquarter Billerica, United States
- Employees 17 as on 31 Dec, 2024
- Founders Bryan Hassell
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nirrin Technologies, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.82 M (USD)
in 2 rounds
-
Latest Funding Round
$4.82 M (USD), Series A
Feb 01, 2024
- Investors
-
Employee Count
17
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nirrin Technologies
Nirrin Technologies offers a comprehensive portfolio of products and services, including Atlas.
Provides rapid real-time monitoring for bioprocess with less sample and cost.
People of Nirrin Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Nirrin Technologies
Nirrin Technologies has successfully raised a total of $4.82M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.82 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nirrin Technologies
Nirrin Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gamma Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A life sciences tools platform is operated by Gamma Biosciences.
|
Locked | Locked | Locked |
Investor details for Nirrin Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nirrin Technologies
Investment portfolio details for Nirrin Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nirrin Technologies
Detailed financials for Nirrin Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nirrin Technologies Comparisons
Peer comparison for Nirrin Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nirrin Technologies
Nirrin Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unibio, Univercells Tech, Pow.Bio, Caladan Bio and BiOZEEN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal feed supplements are produced using proprietary fermentation technology.
|
|
| Locked | Locked | Locked |
Intensified biomanufacturing technologies for viral production are developed and manufactured.
|
|
| Locked | Locked | Locked |
Intelligent fermentation services for industrial and synthetic biology are provided.
|
|
| Locked | Locked | Locked |
Modular bioreactors are developed for biotechnology research applications.
|
|
| Locked | Locked | Locked |
Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals.
|
Detailed competitors of Nirrin Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nirrin Technologies
Complete news archive for Nirrin Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirrin Technologies
Nirrin Technologies was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Nirrin Technologies is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.
Jonathan Hartmann is the current CEO of Nirrin Technologies.
Nirrin Technologies is a funded company, having raised a total of $4.82M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Nirrin Technologies is 17.
Founded in 2018, Nirrin Technologies operates in the biotechnology sector, focusing on sensor and integration solutions for continuous bioprocess control. Products such as the CellStat system, RTA-2300, RTA-1550, and RTA-2300 Perfusion are offered, along with bioLogYx software for digital and analog communications. The company is based in Billerica, United States, supporting automation in bioprocessing applications.
Nirrin Technologies's top competitors include Unibio, Univercells Tech and Pow.Bio.
Nirrin Technologies offers Atlas.
Nirrin Technologies has 1 investor. Key investors include Gamma Biosciences.